Status epilepticus (SE) is a major neurological disorder and SE survivors often develop acquired epilepsy and cognitive deficits. Thus, it is important to stop SE and limit brain damage. However, rapid pharmacoresistance develops to anticonvulsants as seizure duration lengthens. Recently, acetaminophen was reported to increase endocannabinoid levels by its conversion to AM 404. Further, cannabinoids are potent anticonvulsants. Here we investigated whether acetaminophen would block SE-like activity in hippocampal neurons. Exposure of cultured hippocampal neurons to a low Mg 2 + medium elicits highfrequency epileptiform discharges that exceed 3 Hz (invitro SE). Acetaminophen (500 lM) blocks the SE-like activity. CB1 receptor antagonist SR 141716A (1 lM) blocked this inhibitory effect of acetaminophen on SE, indicating that acetaminophen was mediating its anticonvulsant effects through CB1 receptors.
Introduction
Status epilepticus (SE) is a major neurological disorder associated with significant morbidity and mortality. SE causes significant damage to limbic system and patients surviving SE have a very high probability for developing acquired epilepsy and cognitive deficits [1] . It is, therefore, important to stop SE and limit brain damage as early as possible. Unfortunately, SE has been found to be refractory to many treatments and there is rapid development of tolerance to standard anticonvulsant drugs as the seizure duration lengthens [2] . Thus, there is a need to develop newer drugs and treatment strategies for the prompt treatment of SE.
Exposure of cultured hippocampal neurons to a low Mg 2 + medium elicits high-frequency epileptiform discharges in neurons that exceed 3 Hz in the spike frequency. This model has been widely used to study SE mechanisms in an in-vitro setting [3] [4] [5] [6] . It is considered a model of refractory SE, as standard anticonvulsant drugs such as phenytoin and phenobarbital do not stop the high-frequency epileptiform discharges [7] . In addition, similar to humans [8] , benzodiazepines such as lorazepam stop SE-like activity only initially and then develop pharmacoresistance resulting in a loss of efficacy as SE continues [7] . Molecular changes such as loss of GABA A receptors after SE seen in animals are also observed in this preparation [4] . This in-vitro model allows for precise control of extracellular milieu while mimicking electrographic properties, neuronal population synchronicity, and anticonvulsant sensitivity identical to SE observed in vivo and is therefore ideally suited to evaluate the effects of investigational compounds on SE-like activity.
The endocannabinoid system has come to the forefront as a novel target for the treatment of seizures. This system is comprised of at least two cannabinoid receptors (CB1 and CB2), the endogenous ligands (anandamide and 2arachidonyl glycerol), and the protein machinery for the synthesis, degradation, and reuptake of endocannabinoids. CB1 receptors are abundant in the hippocampus and are located on both excitatory and inhibitory nerve terminals. The activation of inhibitory G-protein-coupled presynaptic CB1 receptors results in decreased neurotransmitter release (reviewed in: [9] ). This action is thought to underlie the potent anticonvulsant effects of CB1 agonists in models of acquired epilepsy [10] [11] [12] . Plasticity changes in the endocannabinoid system have also been found after febrile seizure [13] . Cannabinoids have also been found to stop SE-like activity in hippocampal neuronal cultures [7] . It has also been reported that a CB1 receptor-dependent endocannabinoid tone plays an important role in modulating seizure frequency and duration and preventing the development of SE-like activity in epileptic neurons [14, 15] . Thus, the endocannabinoid system plays a critical role in modulating the neuronal excitability.
The development of medicinal cannabinoids has been greatly hampered by psychoactivity and abuse potential associated with CB1 agonists. Altering endocannabinoid levels by targeting enzymes that synthesize and degrade the endogenous ligand is thought to be an attractive strategy for the therapeutic modulation of the endocannabinoid system [9] . In this regard, the endocannabinoid reuptake inhibitors and fatty acid amide hydrolase inhibitors have been found to exert effects similar to CB1 receptor agonists but are not associated with abuse liability [16] . Acetaminophen or paracetamol has recently been suggested as a prodrug for activating the endocannabinoid system [17] . This commonly used analgesic or antipyretic drug was reported to undergo deacetylation and then conjugation with arachidonic acid to yield N-arachidonoyl-phenolamine or AM 404: a potent endocannabinoid reuptake inhibitor [18] . AM 404 has been reported to increase levels on anandamide [19] . This conversion of acetaminophen to AM 404 is thought to underlie its pain alleviating effect as CB1 receptor antagonist blocked its analgesic effect in various pain models [20] [21] [22] . In addition, acetaminophen has also been reported to exhibit anxiolytic properties that are thought to be mediated by endocannabinoids and CB1 receptors [23] . We have previously showed that endocannabinoids block SE-like activity in vitro [3] . Further, AM 404 has been shown to prevent naloxone-induced seizures [24] . In light of these studies, we investigated whether acetaminophen by its conversion to AM 404 and subsequent increases in endocannabinoid levels would block low Mg 2 + -induced, SE-like activity in cultured hippocampal neurons.
Methods
Acetaminophen was purchased from Sigma-Aldrich Co. (St Louis, Missouri, USA) and was dissolved in ethanol. CB1 receptor antagonist, SR141716A, was supplied through the National Institute on Drug Abuse, Chemical Synthesis and Drug Supply Program and was made up in a vehicle stock solution of absolute ethanol, Emulphor-620 (Rhone-Poulenc Inc., Princeton, New Jersey, USA) and 0.9% saline at a ratio of 1 : 1 : 18, which were then diluted at a minimum of 1 : 500 to a final working concentration in the physiological bath recording solution (pBRS) consisting of (in mM): 145 NaCl, 2.5 KCl, 10 HEPES, 2 CaCl 2 , 1 MgCl 2 , 10 glucose, and 0.002 glycine, pH 7.3, and osmolarity (325 ± 5 mOsm) adjusted with sucrose. All the drugs were bath applied using a multivalve perfusion assembly (Warner Instrument Corporation, Connecticut, USA).
All animal use procedures were in strict accordance with the National Institutes of Health Guide for the care and use of laboratory animals and approved by Virginia Commonwealth University's Institutional Animal Care and Use Committee. Studies were conducted on primary mixed hippocampal neuronal cultures prepared as described earlier with slight modifications [10] . In brief, hippocampal cells were obtained from 2-day postnatal Sprague-Dawley rats (Harlan, Frederick, Maryland, USA) and plated at a density of 2.5 Â 10 4 cells/cm 2 onto a glial support layer plated earlier onto poly-l-lysine coated (0.05 mg/ml), 35-mm Falcon cell culture dishes (B-D& Co., Franklin Lakes, New Jersey, USA). Cultures were maintained at 371C in 5% CO 2 at 95% air atmosphere and fed twice weekly with a neuronal feed condition medium. After 2 weeks, cultures were used for experimentation. Continuous epileptiform bursts (SE) were induced by exposing neuronal cultures to pBRS without added MgCl 2 (low Mg 2 + ). The SE continued until pBRS-containing MgCl 2 (1 mM) was added back to the cultures [3] .
Whole-cell current clamp recordings were made using the earlier established procedures [3] . In brief, the cell culture dish was mounted on the stage of an inverted microscope (Nikon Diaphot, Tokyo) continuously perfused with pBRS. Patch electrodes with a resistance of 2-4 MO were pulled on a Brown-Flaming P-80C electrode puller (Sutter Instruments, Novato, California, USA), fire polished and filled with a solution containing the following (in mM): 140 K + gluconate, 1 MgCl 2 and 10 Na-HEPES, pH 7.2, osmolarity (290 ± 10 mOsm) adjusted with sucrose. Recordings were made using an Axopatch 200B amplifier (Molecular Devices, Foster City, California, USA) in current-clamp mode. Data were digitized and transferred to a videotape using a PCM device (Neurocorder, New York, USA) and then played back on a DC-500 Hz chart recorder (Dash II, Astro-Med, Warwick, Rhode Island, USA).
Data are expressed as mean ± standard error of the mean and were analyzed by SigmaPlot 10 (SPSS Inc., Chicago, Illinois, USA) using a one-way analysis of variance with post-hoc Tukey's test. Experiments were performed on different cells and not in a repeat measures mode.
Results
Recordings from control neurons showed occasional action potentials as shown in Fig. 1a (n = 10 neurons). As shown in Fig. 1b , removal of Mg 2 + from the pBRS resulted in the development of continuous highfrequency epileptiform discharges in cultured hippocampal neurons (n = 20 neurons). This epileptiform activity consisted of repetitive burst discharges with each burst comprised of multiple spikes overlaying a paroxysmal depolarization shift. Spike frequency upon exposure to the low Mg 2 + medium exceeded 3 Hz meeting the criteria of electrographic SE. The spiking was continuous and did not slow down throughout the 60 min of recording. Neurons were recorded for 15 min in low Mg 2 + solution before the application of acetaminophen. Acetaminophen (500 mM) was bath applied after the induction of low Mg 2 + induced SE. As shown in Fig. 1c , acetaminophen blocked low Mg 2 + -induced, SE-like activity (n = 30 neurons). At 15 min after acetaminophen perfusion the spike frequency was not significantly different from low Mg 2 + condition (Table 1) . However, by 30 min the SE-like activity was significantly blocked. Similarly, there was a time lag in the inhibitory effect of acetaminophen to dissipate after washout of the drug. Twenty minutes after the washout of acetaminophen, the spike frequency was still significantly depressed and the neurons reverted to low Mg 2 + alone spike frequencies by 45 mins Table 1 . Recent studies have shown that acetaminophen exerts analgesic and anxiolytic effect by CB1 receptors. We coapplied acetaminophen (500 mM) with the CB1 antagonist, SR 141716A (1 mM). As shown in Fig. 1d , SR 141716A blocked the effect of acetaminophen on SE suggesting that acetaminophen was mediating its anti-SE effect by CB1 receptors (n = 20 neurons). The effect of acetaminophen on spike frequencies has been quantified in Table 1 . SR 141716A alone did not have any effect on control or low Mg 2 +treated neurons (data not shown and see: [14] ).
Discussion
This study for the first time reports an inhibitory effect of acetaminophen on low Mg 2 + -induced, SE-like activity in cultured hippocampal neurons. The onset of acetaminophen action was delayed and was maximally effective by approximately 30 min, at which time it inhibited the high-frequency spiking activity characteristic of SE. The results suggest that there is a time lag for conversion of acetaminophen to AM 404 and then for subsequent buildup of endocannabinoids to concentrations high enough to stop the SE-like activity. This is in line with the observation by Hogestatt et al. [18] , who reported that AM 404 was detectable in rat brains 20 min after an (300 mg/kg, intraperitoneally) injection of acetaminophen. After acetaminophen washout, the SE-like activity remained inhibited for almost 20 min despite the presence of low Mg 2 + medium and then returned to preacetaminophen levels by 45 min. The results indicate that after the removal of acetaminophen, endocannabinoid levels remain elevated at concentrations sufficient to inhibit high-frequency spiking before the transporters reduced their levels. A 500-mM dose of acetaminophen was chosen, as Hogestatt et al. [18] also showed that significant accumulations of AM 404 in brain homogenates occurred only beyond 100-mM concentration. Although we did observe a reduction in SE-like activity at 300-mM dose of acetaminophen (data not shown), to maximize the formation of AM 404 we chose the 500-mM concentration. A dose-response relationship would be noted in future studies to find the ED 50 concentration of acetaminophen to stop the SE-like activity. Although coapplication of SR 141716A produced a significant inhibition of acetaminophen's effect, it could not revert the neuron to low Mg 2 + alone spike patterns suggesting the involvement of mechanisms beyond the CB1 receptor activation. Indeed, acetaminophen and, in turn, AM 404 are potent COX-2 and prostaglandin synthesis inhibitors [18] . These inflammatory molecules are upregulated during seizure events and their inhibition along with the CB1 receptor activation could underlie the inhibitory effect of acetaminophen on SE-like activity. It will also be interesting to investigate the interaction between diazepam and acetaminophen in our in-vitro model of SE. The slow onset suggests that SE would remain inhibited by the time benzodiazepines start to lose their efficacy and therefore acetaminophen could be a novel adjuvant to benzodiazepines for the treatment of SE. Indeed, acetaminophen has been reported to enhance the protective activity of valproate against maximal electroshock-induced seizures [25] . 
